Obesity News

Medindia's Press Release’ section provides the latest press release on Obesity from across the world for the global audience. This page links to 480 Obesity press releases.

Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss

PR Newswire SEOUL, South Korea, Nov. 6, 2024 Fat Loss Augmentation + Lean Mass Increase Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeekHigh Quality Obesity Management by Targeting the CRF2 Receptor: ...


Los Angeles Bariatric Surgeon, Dr. David Davtyan, Honored as Fellow of the American Society for Metabolic & Bariatric Surgery (FASMBS)

PR Newswire BEVERLY HILLS, Calif., Nov. 4, 2024 Dr. David Davtyan, a renowned bariatric surgeon in Los Angeles, has been awarded the prestigious title of Fellow of the American Society for Metabolic & Bariatric Surgery (FASMBS) in ...

Affidea Group partners with Reset Health to launch clinically-led digital weight loss and diabetes management solution across its network

PR Newswire THE HAGUE, Netherlands, Nov. 4, 2024 Affidea introduces the Roczen platform from Reset Health for the management of obesity and type 2 diabetes, offering personalised care, GLP-1 medications, and improved health outcomes for ...

Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek® 2024

PR Newswire SAN DIEGO, Nov. 4, 2024  Up to 6.8% Placebo-Adjusted Mean Weight Loss (8.2% from Baseline) After 28 Days of Dosing with Oral Tablet of VK2735  Encouraging Tolerability Through 100 mg Daily Dosing with Oral VK2735; Mild ...

Congruence Therapeutics Announces Blitz Talk Award and Poster Presentations on MC4R-Deficient Genetic Obesity Program at Obesity Week 2024

PR Newswire MONTREAL, Nov. 3, 2024 - Congruence has been awarded the Neuroscience Section Blitz Talk Award for transformative research in MC4R-related early-onset genetic obesity - - Congruence's insights into the biology and ...

Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2024

PR Newswire SAN DIEGO, Oct. 28, 2024 Results from VENTURE Phase 2 Study of Subcutaneous VK2735 in Obese Patients and Phase 1 Trial of Oral VK2735 in Healthy Subjects to be Presented SAN DIEGO, Oct. 28, 2024 /PRNewswire/ -- Viking ...

Prime Therapeutics GLP-1 research: Year-2 cost of care is $4,200 higher for patients with obesity

PR Newswire EAGAN, Minn., Oct. 24, 2024 Real-world study of GLP-1 patients continues to deliver leading insights EAGAN, Minn., Oct. 24, 2024 /PRNewswire/ -- In the latest findings from its industry-leading study, Prime Therapeutics ...

Optimizing Obesity Trials: Integrating Diverse Endpoints to Holistically Assess Safety and Efficacy of GLP-1 Agonists and Beyond, Upcoming Webinar Hosted by Xtalks

PR Newswire TORONTO, Oct. 22, 2024 In this free webinar, learn about how obesity and diabetes drug development requires monitoring for hypoglycemia with a blood glucose meter (BGM) for regulatory submission. Attendees will learn how GLP-1 ...

Genomics releases new research showing significant link between genetic risk and obesity

PR Newswire OXFORD, England, Oct. 15, 2024 OXFORD, England, Oct. 15, 2024 /PRNewswire/ -- Genomics' latest groundbreaking research, showcased at the Bupa Health Symposium, shows that a person's genetic background is a key driver for their ...

Primary Care Center of Clear Lake Strengthens Care Expertise With Certification of Two Physicians in Obesity Medicine

PR Newswire WEBSTER, Texas, Oct. 15, 2024 WEBSTER, Texas, Oct. 15, 2024 /PRNewswire/ -- The Primary Care Center of Clear Lake is proud to announce that two of its physicians, Dr. Smriti Choudhary and Dr. Niraj Choudhary, have been certified ...

Obesity News »

Diet and Lifestyle Crisis Fuels India's Abdominal Obesity

Diet and Lifestyle Crisis Fuels India's Abdominal Obesity

Soumya Swaminathan, former WHO Chief Scientist, highlights that the rise in abdominal obesity in India is largely due to unhealthy diets and a lack of physical activity, pointing to a significant public health concern ( ). ...

Muscle Risk in Weight-Loss Medication

Muscle Risk in Weight-Loss Medication

Essential need to preserve skeletal muscle mass when using GLP-1 receptor agonists for weight loss has been highlighted in the Lancet editorial. Although effective for obesity treatment, these medications raise concerns over the potential for ...

Expanding Access to Weight Loss Drugs Could Save Lives

Expanding Access to Weight Loss Drugs Could Save Lives

Expanding access to new and highly effective weight-loss medications could save over 40,000 deaths every year in the United States ( ). A recent study by the Yale School of Public Health and the University of Florida, explains the ...

Simple Blood Test Offers Early Detection of Obesity-Related Risks in Kids

Simple Blood Test Offers Early Detection of Obesity-Related Risks in Kids

New blood test has been developed that measures lipids to identify children at risk of obesity-related complications, including type 2 diabetes , liver disease , and heart disease , as per a study from King’s College London published in Nature ...

Obesity Care Crisis: Underfunded Services Limiting Access to Treatment

Obesity Care Crisis: Underfunded Services Limiting Access to Treatment

A BMJ investigation has uncovered a widespread lack of access to obesity care in England. Nearly half of the country's patients cannot see specialist weight loss teams, and...

More Obesity News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.